Director/PDMR Shareholding

RNS Number : 5542J

AstraZeneca PLC

31 March 2010

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

We hereby inform you that on 30 March 2010, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below.  The change in interest relates to the vesting of previously announced awards made in March 2007 under the AstraZeneca Performance Share Plan or, for Jeff Pott and Lynn Tetrault, the AstraZeneca Executive Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to 78% of the shares originally awarded.  In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed.  In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.  The interests of Jeff Pott, Lynn Tetrault and Tony Zook are in the Company's American Depositary Shares (ADSs).  One ADS equals one Ordinary Share.

Name	Gross Shares Awarded	Shares Lapsed	Shares Vested	Shares Withheld	Net Shares Received	Market Price on Vesting
Anders Ekblom	3,143	692	2,451	0	2,451	2980p
Jeff Pott	2,973	655	2,318	1,046	1,272	$44.90
David Smith	16,399	3,608	12,791	5,245	7,546	2980p
Lynn Tetrault	10,227	2,250	7,977	2,933	5,044	$44.90
Tony Zook	40,817	8,980	31,837	13,098	18,739	$44.90

A C N Kemp

Company Secretary

31 March 2010

 

END

 

 

RDSUARVRRSAOOAR